NRIX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Nurix Therapeutics Inc (NRIX).


$1.57B Market Cap.

As of 01/28/2025 5:00 PM ET (MRY) • Disclaimer

NRIX Market Cap. (MRY)


NRIX Shares Outstanding (MRY)


NRIX Assets (MRY)


Total Assets

$669.34M

Total Liabilities

$142.35M

Total Investments

$499.59M

NRIX Income (MRY)


Revenue

$54.55M

Net Income

-$193.57M

Operating Expense

$267.58M

NRIX Cash Flow (MRY)


CF Operations

-$172.58M

CF Investing

-$257.71M

CF Financing

$485.67M

NRIX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

NRIX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$669,343,000 (88.23%)

$355,598,000 (-14.68%)

$416,759,000 (-12.59%)

$476,771,000 (20.29%)

Assets Current

$619,387,000 (109.60%)

$295,503,000 (-7.21%)

$318,449,000 (2.36%)

$311,118,000 (4.25%)

Assets Non-Current

$49,956,000 (-16.87%)

$60,095,000 (-38.87%)

$98,310,000 (-40.65%)

$165,653,000 (69.19%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$526,993,000 (162.85%)

$200,493,000 (-33.98%)

$303,696,000 (-11.28%)

$342,302,000 (17.93%)

Property Plant & Equipment Net

$45,896,000 (-4.28%)

$47,950,000 (62.50%)

$29,508,000 (16.43%)

$25,345,000 (279.87%)

Cash & Equivalents

$110,898,000 (99.72%)

$55,528,000 (-15.06%)

$65,375,000 (-19.08%)

$80,792,000 (-32.41%)

Accumulated Other Comprehensive Income

$150,000 (122.90%)

-$655,000 (84.83%)

-$4,319,000 (-610.36%)

-$608,000 (-798.85%)

Deferred Revenue

$64,571,000 (-30.66%)

$93,120,000 (26.51%)

$73,607,000 (-26.56%)

$100,234,000 (7.22%)

Total Investments

$499,586,000 (107.55%)

$240,702,000 (-21.99%)

$308,546,000 (-12.45%)

$352,403,000 (39.47%)

Investments Current

$499,586,000 (114.16%)

$233,281,000 (-4.65%)

$244,667,000 (13.69%)

$215,214,000 (33.02%)

Investments Non-Current

$0 (0%)

$7,421,000 (-88.38%)

$63,879,000 (-53.44%)

$137,189,000 (50.94%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$6,000,000 (0%)

Trade & Non-Trade Payables

$11,482,000 (79.38%)

$6,401,000 (26.40%)

$5,064,000 (-23.85%)

$6,650,000 (94.90%)

Accumulated Retained Earnings (Deficit)

-$738,769,000 (-35.50%)

-$545,200,000 (-35.87%)

-$401,252,000 (-81.65%)

-$220,892,000 (-113.01%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$204,000 (-94.70%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$28,303,000 (-7.55%)

$30,614,000 (155.88%)

$11,964,000 (-8.22%)

$13,036,000 (0%)

Debt Current

$8,014,000 (7.01%)

$7,489,000 (35.42%)

$5,530,000 (43.75%)

$3,847,000 (0%)

Debt Non-Current

$20,289,000 (-12.26%)

$23,125,000 (259.42%)

$6,434,000 (-29.98%)

$9,189,000 (0%)

Total Liabilities

$142,350,000 (-8.22%)

$155,105,000 (37.18%)

$113,063,000 (-15.92%)

$134,469,000 (26.77%)

Liabilities Current

$95,854,000 (10.23%)

$86,958,000 (23.07%)

$70,655,000 (6.64%)

$66,258,000 (48.76%)

Liabilities Non-Current

$46,496,000 (-31.77%)

$68,147,000 (60.69%)

$42,408,000 (-37.83%)

$68,211,000 (10.85%)

NRIX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$54,549,000 (-29.15%)

$76,987,000 (99.31%)

$38,627,000 (29.84%)

$29,750,000 (66.95%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$45,944,000 (7.09%)

$42,902,000 (12.91%)

$37,997,000 (21.78%)

$31,202,000 (91.32%)

Research & Development Expense

$221,632,000 (17.17%)

$189,148,000 (2.52%)

$184,497,000 (58.46%)

$116,434,000 (75.10%)

Operating Expenses

$267,576,000 (15.31%)

$232,050,000 (4.29%)

$222,494,000 (50.70%)

$147,636,000 (78.30%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$270,000 (0%)

$0 (0%)

$0 (0%)

$131,000 (100.64%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$193,569,000 (-34.47%)

-$143,948,000 (20.19%)

-$180,360,000 (-53.90%)

-$117,194,000 (-171.02%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$193,569,000 (-34.47%)

-$143,948,000 (20.19%)

-$180,360,000 (-53.90%)

-$117,194,000 (-171.02%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$193,569,000 (-34.47%)

-$143,948,000 (20.19%)

-$180,360,000 (-53.90%)

-$117,194,000 (-171.02%)

Weighted Average Shares

$67,120,266 (23.52%)

$54,337,901 (11.79%)

$48,607,990 (13.32%)

$42,895,383 (173.68%)

Weighted Average Shares Diluted

$67,120,266 (23.52%)

$54,337,901 (11.79%)

$48,607,990 (13.32%)

$42,895,383 (173.68%)

Earning Before Interest & Taxes (EBIT)

-$193,299,000 (-34.28%)

-$143,948,000 (20.19%)

-$180,360,000 (-54.07%)

-$117,063,000 (-83.55%)

Gross Profit

$54,549,000 (-29.15%)

$76,987,000 (99.31%)

$38,627,000 (29.84%)

$29,750,000 (66.95%)

Operating Income

-$213,027,000 (-37.38%)

-$155,063,000 (15.67%)

-$183,867,000 (-55.97%)

-$117,886,000 (-81.41%)

NRIX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$257,713,000 (-477.32%)

$68,301,000 (151.13%)

$27,198,000 (125.12%)

-$108,251,000 (57.45%)

Net Cash Flow from Financing

$485,667,000 (14996.89%)

$3,217,000 (-97.25%)

$117,192,000 (-23.84%)

$153,882,000 (-54.61%)

Net Cash Flow from Operations

-$172,584,000 (-112.11%)

-$81,365,000 (49.09%)

-$159,807,000 (-89.42%)

-$84,365,000 (-105356.25%)

Net Cash Flow / Change in Cash & Cash Equivalents

$55,370,000 (662.30%)

-$9,847,000 (36.13%)

-$15,417,000 (60.20%)

-$38,734,000 (-145.82%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$248,440,000 (-423.90%)

$76,702,000 (94.47%)

$39,442,000 (138.45%)

-$102,590,000 (58.94%)

Capital Expenditure

-$9,273,000 (-10.38%)

-$8,401,000 (31.39%)

-$12,244,000 (-116.29%)

-$5,661,000 (-24.34%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$485,667,000 (14996.89%)

$3,217,000 (-97.25%)

$117,192,000 (-23.84%)

$153,882,000 (-29.77%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$33,929,000 (0.76%)

$33,673,000 (19.70%)

$28,131,000 (78.04%)

$15,800,000 (267.36%)

Depreciation Amortization & Accretion

$16,428,000 (20.32%)

$13,654,000 (26.33%)

$10,808,000 (77.70%)

$6,082,000 (178.99%)

NRIX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-354.90% (-89.79%)

-187.00% (59.95%)

-466.90% (-18.53%)

-393.90% (-62.30%)

EBITDA Margin

-324.20% (-91.61%)

-169.20% (61.45%)

-438.90% (-17.67%)

-373.00% (-7.90%)

Return on Average Equity (ROAE)

-53.60% (9.92%)

-59.50% (-0.51%)

-59.20% (-75.15%)

-33.80% (9.14%)

Return on Average Assets (ROAA)

-38.60% (7.21%)

-41.60% (1.42%)

-42.20% (-69.48%)

-24.90% (-27.04%)

Return on Sales (ROS)

-354.40% (-89.52%)

-187.00% (59.95%)

-466.90% (-18.65%)

-393.50% (-9.95%)

Return on Invested Capital (ROIC)

-55.60% (6.87%)

-59.70% (-3.47%)

-57.70% (-40.73%)

-41.00% (27.56%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-7.68 (-227.10%)

-2.35 (29.73%)

-3.34 (68.36%)

-10.56 (31.63%)

Price to Sales Ratio (P/S)

27.2 (519.70%)

4.39 (-71.84%)

15.59 (-62.48%)

41.55 (10.85%)

Price to Book Ratio (P/B)

2.97 (97.48%)

1.5 (-21.78%)

1.92 (-48.78%)

3.76 (-34.16%)

Debt to Equity Ratio (D/E)

0.27 (-65.12%)

0.77 (108.06%)

0.37 (-5.34%)

0.39 (7.67%)

Earnings Per Share (EPS)

-2.88 (-8.68%)

-2.65 (28.57%)

-3.71 (-35.90%)

-2.73 (1.09%)

Sales Per Share (SPS)

0.81 (-42.63%)

1.42 (78.24%)

0.8 (14.55%)

0.69 (-38.96%)

Free Cash Flow Per Share (FCFPS)

-2.71 (-63.98%)

-1.65 (53.33%)

-3.54 (-68.65%)

-2.1 (-609.12%)

Book Value Per Share (BVPS)

7.85 (112.76%)

3.69 (-40.94%)

6.25 (-21.70%)

7.98 (-56.91%)

Tangible Assets Book Value Per Share (TABVPS)

9.97 (52.38%)

6.54 (-23.68%)

8.57 (-22.86%)

11.12 (-56.05%)

Enterprise Value Over EBIT (EV/EBIT)

-8 (-300.00%)

-2 (33.33%)

-3 (70.00%)

-10 (54.55%)

Enterprise Value Over EBITDA (EV/EBITDA)

-8.44 (-312.86%)

-2.04 (36.84%)

-3.24 (68.42%)

-10.25 (54.57%)

Asset Turnover

0.11 (-50.90%)

0.22 (146.67%)

0.09 (42.86%)

0.06 (-22.22%)

Current Ratio

6.46 (90.17%)

3.4 (-24.61%)

4.51 (-4.02%)

4.7 (-29.92%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$181,857,000 (-102.59%)

-$89,766,000 (47.83%)

-$172,051,000 (-91.11%)

-$90,026,000 (-1843.15%)

Enterprise Value (EV)

$1,493,388,195 (460.39%)

$266,492,437 (-51.45%)

$548,945,007 (-51.76%)

$1,138,010,487 (-18.15%)

Earnings Before Tax (EBT)

-$193,299,000 (-34.28%)

-$143,948,000 (20.19%)

-$180,360,000 (-54.07%)

-$117,063,000 (-83.55%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$176,871,000 (-35.75%)

-$130,294,000 (23.15%)

-$169,552,000 (-52.78%)

-$110,981,000 (-80.17%)

Invested Capital

$490,894,000 (101.41%)

$243,726,000 (-16.73%)

$292,693,000 (-14.61%)

$342,757,000 (47.56%)

Working Capital

$523,533,000 (151.04%)

$208,545,000 (-15.84%)

$247,794,000 (1.20%)

$244,860,000 (-3.56%)

Tangible Asset Value

$669,343,000 (88.23%)

$355,598,000 (-14.68%)

$416,759,000 (-12.59%)

$476,771,000 (20.29%)

Market Capitalization

$1,566,190,195 (419.13%)

$301,693,437 (-48.35%)

$584,161,007 (-54.57%)

$1,285,736,487 (-22.36%)

Average Equity

$360,822,500 (49.06%)

$242,070,750 (-20.56%)

$304,724,250 (-12.05%)

$346,457,500 (197.96%)

Average Assets

$501,662,000 (44.93%)

$346,142,750 (-18.94%)

$427,031,750 (-9.36%)

$471,121,500 (113.96%)

Invested Capital Average

$347,567,250 (44.14%)

$241,134,250 (-22.89%)

$312,696,250 (9.49%)

$285,580,500 (153.62%)

Shares

70,836,282 (46.04%)

48,503,768 (2.88%)

47,147,781 (5.68%)

44,612,647 (14.82%)